GLYCYROSS-MP2 SR TAB
— Product

GLYCYROSS-MP2 SR TAB

GLIMEPIRIDE 2MG + METFORMIN + PIOGLITAZONE 15MG

GLYCYROSS-MP2 SR TAB is a tablet combining glimepiride 2 mg, metformin and pioglitazone 15 mg, a triple oral combination for type 2 diabetes mellitus. It is used where dual therapy has failed to achieve adequate glycaemic control, adding a thiazolidinedione to improve insulin sensitivity further.

01

Benefits

  • Three complementary mechanisms — reduced hepatic glucose output, stimulated insulin secretion, and improved peripheral insulin sensitivity.
  • Pioglitazone acts on muscle and fat tissue to improve insulin sensitivity, addressing a mechanism the other two do not.
  • Pioglitazone has a durable glucose-lowering effect that is maintained over years better than sulphonylureas alone.
  • A single tablet replaces three, which matters substantially for adherence.
  • Useful in markedly insulin-resistant patients where metformin and a sulphonylurea are insufficient.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Hypoglycaemia — sweating, tremor, hunger, palpitations, confusion
  • Weight gain, from both the glimepiride and the pioglitazone
  • Fluid retention and ankle swelling
  • Nausea or diarrhoea
Less common
  • Anaemia
  • Headache or dizziness
  • Vitamin B12 deficiency with long-term metformin use
  • Visual disturbance from macular oedema
Stop and get medical help if any of these occur
  • Breathlessness, rapid weight gain or marked swelling of the legs — this may be heart failure
  • Severe hypoglycaemia with confusion, seizures or loss of consciousness
  • Deep rapid breathing, severe weakness and vomiting — this may be lactic acidosis
  • Blood in the urine, or pain or urgency on passing urine
  • Bone pain or a fracture after minor injury
  • Yellowing of the skin or eyes
03

Precautions

  • Pioglitazone causes fluid retention and can precipitate or worsen heart failure. Contraindicated in heart failure of any grade, and stop immediately if breathlessness, oedema or rapid weight gain develops.
  • Pioglitazone increases fracture risk, particularly in women, and has been associated with bladder cancer — contraindicated in active bladder cancer or unexplained haematuria.
  • Glimepiride causes hypoglycaemia, which can be severe and prolonged. Patients must know the symptoms and carry fast-acting glucose, and never skip meals.
  • Metformin can cause lactic acidosis — stop during acute illness with dehydration, before contrast procedures and before major surgery.
  • Contraindicated in type 1 diabetes, diabetic ketoacidosis, significant renal impairment, hepatic impairment and active liver disease.
  • Check liver function before starting pioglitazone and periodically thereafter.
  • Swallow the sustained-release tablet whole, take with the first main meal, and avoid excess alcohol.
  • Contraindicated in pregnancy and breastfeeding. This triple combination should be reviewed regularly rather than continued indefinitely without reassessment.